2142-06-5

Basic information

• Product Name: 1-benzylpyrrolidine-2,5-dione
• Synonyms: 1-benzylpyrrolidine-2,5-dione;N-Benzylsuccinimide
• CAS NO: 2142-06-5
• Molecular Formula: C₁₁H₁₁NO₂
• Molecular Weight: 189.213
• Mol File: 2142-06-5.mol
• Article Data: 82

Chemical Properties

• Melting Point: 103°C
• Boiling Point: 324.47°C (rough estimate)
• Flash Point: 194.1°C
• Appearance: /
• Density: 1.1596 (rough estimate)
• Vapor Pressure: 1.97E-06mmHg at 25°C
• Refractive Index: 1.5012 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -1.37±0.20(Predicted)
• CAS DataBase Reference: 1-benzylpyrrolidine-2,5-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzylpyrrolidine-2,5-dione(2142-06-5)
• EPA Substance Registry System: 1-benzylpyrrolidine-2,5-dione(2142-06-5)

Safety Data

• Hazardous Substances Data: 2142-06-5(Hazardous Substances Data)

Usage

General Description

1-benzylpyrrolidine-2,5-dione is a chemical compound that belongs to the class of pyrrolidine-2,5-dione derivatives. It is a white solid with a molecular formula of C12H13NO2 and a molecular weight of 203.23 g/mol. 1-benzylpyrrolidine-2,5-dione is used in the field of organic synthesis, particularly in the production of pharmaceuticals and agrochemicals. It has been identified as a potential intermediate in the synthesis of various biologically active compounds. Additionally, research has shown that 1-benzylpyrrolidine-2,5-dione exhibits anti-inflammatory and analgesic properties, making it a promising candidate for further drug development. Overall, 1-benzylpyrrolidine-2,5-dione is a versatile chemical with various potential applications in pharmaceutical and agricultural industries.

InChI:InChI=1/C11H11NO2/c13-10-6-7-11(14)12(10)8-9-4-2-1-3-5-9/h1-5H,6-8H2

Upstream product

• 1466-67-7 1,3-dibenzylurea 
• 543-20-4 succinoyl dichloride 
• 64984-60-7 4-oxo-4-[(phenylmethyl)amino]butanoic acid 
• 108-30-5 succinic acid anhydride 
• 100-46-9 benzylamine 
• 123-56-8 Succinimide 
• 100-39-0 benzyl bromide 
• 100-42-5 styrene 
• 1631-26-1 1-benzyl-1H-pyrrole-2,5-dione 
• 1108168-90-6 5-(2-bromophenyl)-4-oxo-pentanoic acid benzylamide 
• 128-09-6 N-chloro-succinimide 
• 108-88-3 toluene 
• 5291-77-0 1-benzyl-2-pyrrolidone 
• 110-15-6 succinic acid 

Downstream Products

• 159757-34-3 1-benzyl-5-hydroxy-5-(2-phenylethyl)pyrrolidin-2-one 
• 159757-35-4 1-benzyl-5-hydroxy-5-(3-phenylpropyl)pyrrolidin-2-one 
• 29897-82-3 N-benzylpyrrolidine 
• 80301-56-0 1-(4′-nitrobenzyl)pyrrolidine-2,5-dione 
• 302777-37-3 1-benzyl-5-hydroxy-5-(3-trimethylsilylprop-2-ynynl)-pyrrolidin-2-one 
• 587854-63-5 1-benzyl-5-hydroxy-5-[3-(3',4'-methylenedioxyphenyl)propyl]pyrrolidin-2-one 
• 929037-56-9 4-benzyl-4-azaspiro[2.4]heptane-5-one 
• 117416-22-5 7-benzyl-5-vinylidene-7-azabicyclo<4.2.1>nonan-8-one 
• 117416-24-7 7-benzyl-5-vinylidene-7-azabicyclo<4.2.1>nonan-2,8-dione 
• 117416-23-6 7-benzyl-2-hydroxy-5-vinylidene-7-azabicyclo<4.2.1>nonan-8-one 
• 117416-15-6 1-benzyl-5-methoxy-3-<1-hydroxy-6-(trimethylsilyl)-4-hexynyl>-2-pyrrolidinone 
• 117416-14-5 1-benzyl-5-methoxy-3-<6-(trimethylsilyl)-4-hexynyl>-2-pyrrolidinone 

Relevant articles and documents

-

-

NOVEL UREA 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for mating the compounds.

NOVEL INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.